Cell-based model is a crucial tool widely used in the early stage of drug development, which is a generalized modular approach to simulate the disease pathogenesis and detect drug response in vitro in biomedical research of rare diseases. Our company provides multiple approaches and in-depth solutions to help you speed up the development of cell-based models in rare...

Protheragen, a leading biotechnology company specializing in innovative research solutions, announces its comprehensive service portfolio dedicated to rare cancers, addressing the unique challenges these uncommon malignancies present to the medical community and affected patients worldwide. Rare cancers, often referred to as rare cancers, encompass a diverse group of approximately 200...